Thus, to comprehensively understand the mechanism underlying Chk1-modulated downstream genes that interferes proliferation of breast cancer cell caused by diosgenin, consecutive studies to determine phosphorylation of Chk1 resided in different amino acid residue are required for cancer therapy. This evidence concerns the gene CHEK1 and breast carcinoma.